Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Heart Failure Patients
NCT02694289Withdrawn
- Start
- Nov 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms). Primary endpoint: Total units of insulin administered. Planned start Nov 2016; status: withdrawn.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02694289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02694289.